U.S. Headquarters of Iterum Therapeutics Relocates in Chicago

Iterum Therapeutics will occupy space within 200 S. Wacker Drive.

CHICAGO — Iterum Therapeutics US Limited, a subsidiary of Iterum Therapeutics, has signed a 10,318-square-foot office lease at 200 S. Wacker Drive in Chicago to relocate its American headquarters. The Ireland-based pharmaceutical company develops anti-infectives aimed at combatting multi-drug resistant pathogens. The U.S. subsidiary of Iterum Therapeutics is relocating from 200 W. Monroe St. Geoffrey Kasselman, Matthew Whipple, Bob Chodos and Steve Levitas of Newmark Knight Frank represented the tenant in the lease transaction. John Hancock Real Estate owns the building.

Get more news delivered to your inbox. Subscribe to France Media's e-newsletters. Click here.

Related News

Webinars on Demand


Read the Digital Editions

Heartland Recent Issue

Northeast Recent Issue

Southeast Recent Issue

Texas Recent Issue

Western Recent Issue

Shopping Center Business

California Centers

Ancillary Retail

Student Housing Business

Seniors Housing Business

Featured Properties